CrisperWhisper: Accurate Timestamps on Verbatim Speech Transcriptions

We demonstrate that carefully adjusting the tokenizer of the Whisper speech recognition model significantly improves the precision of word-level timestamps when applying dynamic time warping to the decoder's cross-attention scores. We fine-tune the model to produce more verbatim speech transcriptions and employ several techniques to increase robustness against multiple speakers and background noise. These adjustments achieve state-of-the-art performance on benchmarks for verbatim speech transcription, word segmentation, and the timed detection of filler events, and can further mitigate transcription hallucinations. The code is available open https://github.com/nyrahealth/CrisperWhisper.

Careful Whisper -- leveraging advances in automatic speech recognition for robust and interpretable aphasia subtype classification

This paper presents a fully automated approach for identifying speech anomalies from voice recordings to aid in the assessment of speech impairments. By combining Connectionist Temporal Classification (CTC) and encoder-decoder-based automatic speech recognition models, we generate rich acoustic and clean transcripts. We then apply several natural language processing methods to extract features from these transcripts to produce prototypes of healthy speech. Basic distance measures from these prototypes serve as input features for standard machine learning classifiers, yielding human-level accuracy for the distinction between recordings of people with aphasia and a healthy control group. Furthermore, the most frequently occurring aphasia types can be distinguished with 90% accuracy. The pipeline is directly applicable to other diseases and languages, showing promise for robustly extracting diagnostic speech biomarkers.

Artificial Intelligence Decision Support for Medical Triage

Applying state-of-the-art machine learning and natural language processing on approximately one million of teleconsultation records, we developed a triage system, now certified and in use at the largest European telemedicine provider. The system evaluates care alternatives through interactions with patients via a mobile application. Reasoning on an initial set of provided symptoms, the triage application generates AI-powered, personalized questions to better characterize the problem and recommends the most appropriate point of care and time frame for a consultation. The underlying technology was developed to meet the needs for performance, transparency, user acceptance and ease of use, central aspects to the adoption of AI-based decision support systems. Providing such remote guidance at the beginning of the chain of care has significant potential for improving cost efficiency, patient experience and outcomes. Being remote, always available and highly scalable, this service is fundamental in high demand situations, such as the current COVID-19 outbreak.

SAPSAM - Sparsely Annotated Pathological Sign Activation Maps - A novel approach to train Convolutional Neural Networks on lung CT scans using binary labels only

Chronic Pulmonary Aspergillosis (CPA) is a complex lung disease caused by infection with Aspergillus. Computed tomography (CT) images are frequently requested in patients with suspected and established disease, but the radiological signs on CT are difficult to quantify making accurate follow-up challenging. We propose a novel method to train Convolutional Neural Networks using only regional labels on the presence of pathological signs, to not only detect CPA, but also spatially localize pathological signs. We use average intensity projections within different ranges of Hounsfield-unit (HU) values, transforming input 3D CT scans into 2D RGB-like images. CNN architectures are trained for hierarchical tasks, leading to precise activation maps of pathological patterns. Results on a cohort of 352 subjects demonstrate high classification accuracy, localization precision and predictive power of 2 year survival. Such tool opens the way to CPA patient stratification and quantitative follow-up of CPA pathological signs, for patients under drug therapy.